Identifying, Analyzing, and Controlling Particles throughout the Biopharmaceutical Product Lifecycle

Tuesday, March 25, 2014; 11 am-noon Eastern US time AND Tuesday, April 1, 10:00-11:00 Central European time

Biopharmaceuticals need a stable environment to ensure a long product shelf life. One of the main challenges in the development of stable biopharmaceutical products is the control of aggregation and particulate formation. This 60-minute webcast will discuss the mechanisms and processes through which aggregation can occur and ways in which product development teams can investigate particulate formation and its control through early stage formulation development. Experts will discuss how particles can potentially develop through the life cycle of a drug, describe regulatory expectations, and provide a review of analytical techniques available to assess protein aggregation and particulates for innovator drugs and biosimilars. A case study will demonstrate real-world examples of how particulates levels can be higher than expected when preformulation screening is not properly conducted.

Key Learning Objectives:

• Review regulatory expectations and industry concerns about protein aggregation
• Assess the advantages and disadvantages of analytical techniques for measuring particles
• Understand how particles develop during a drug’s lifecycle


Rita Peters

Editorial Director
BioPharm International


Roland Schmidt, PhD

Senior Group Leader, F. Hoffmann-La Roche Ltd.
Pharma Technical Development Europe (Biologics)

Dr. Tara Sanderson
Formulation Services Manager
SGS M-Scan Ltd

This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Sara Barschdorf,

Register for this FREE Webcast!

 If you have previously registered for this event, please login below:

Registration is required to attend this event. Please register now.
First Name*
Last Name*
Job Title*
Organization Name*
Organization Address*
Organization Address 2
State or Province*
Zip/Postal Code*
E-mail address*
Work Phone*
What does your group outsource? (Please check all that apply.)*Container testing (including extractables and leachables)
Method development & validation
Biopharmaceutical/large molecule testing
Stability studies
Do not outsource
Would you like to receive information on future SGS sponsored seminars, webcasts, news and events?*Yes
What future webcast topics would be of interest to you?
You must have javascript and cookies enabled to complete registration.
Please enable Cookies in your browser before registering for the webcast.
*Denotes required.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395.

Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.